<https://rdf.molmedb.upol.cz/reference/ref3794> <http://purl.org/ontology/bibo/pmid> "21189020"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM492100>,
		<https://identifiers.org/molmedb/MM492054>;
	<http://purl.org/ontology/bibo/doi> "10.1021/jm1009082"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM492101>,
		<https://identifiers.org/molmedb/MM492059>;
	<http://purl.org/dc/terms/bibliographicCitation> "Marchais-Oberwinkler S, Wetzel M, Ziegler E, Kruchten P, Werth R, Henn C, Hartmann RW, Frotscher M.: New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases. J Med Chem, Volume 54 (2), 2011"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21>,
		<https://identifiers.org/molmedb/MM492099> .
<https://rdf.molmedb.upol.cz/interaction/int1026981> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3794> .
<https://rdf.molmedb.upol.cz/interaction/int1026984> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3794> .
<https://rdf.molmedb.upol.cz/interaction/int1026865> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3794> .
<https://rdf.molmedb.upol.cz/interaction/int1026982> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3794> .
<https://rdf.molmedb.upol.cz/interaction/int1026889> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3794> .